Corbus Pharmaceuticals Holdings (CRBP) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -14.40% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.41% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 13.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | -53.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.81% |
| Sep 30, 2025 | -51.83% |
| Jun 30, 2025 | -49.84% |
| Mar 31, 2025 | -48.38% |
| Dec 31, 2024 | -45.61% |
| Sep 30, 2024 | -41.95% |
| Jun 30, 2024 | -42.44% |
| Mar 31, 2024 | -39.92% |
| Dec 31, 2023 | -37.93% |
| Sep 30, 2023 | -36.62% |
| Jun 30, 2023 | -34.57% |
| Mar 31, 2023 | -33.42% |
| Dec 31, 2022 | -31.78% |
| Sep 30, 2022 | -28.36% |
| Jun 30, 2022 | -11.94% |
| Mar 31, 2022 | -6.39% |
| Dec 31, 2021 | -4.01% |
| Sep 30, 2021 | -0.61% |
| Jun 30, 2021 | 9.61% |
| Mar 31, 2021 | 13.46% |